Correlation Between DiaMedica Therapeutics and Akari Therapeutics
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Akari Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Akari Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Akari Therapeutics PLC, you can compare the effects of market volatilities on DiaMedica Therapeutics and Akari Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Akari Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Akari Therapeutics.
Diversification Opportunities for DiaMedica Therapeutics and Akari Therapeutics
-0.65 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between DiaMedica and Akari is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Akari Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akari Therapeutics PLC and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Akari Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akari Therapeutics PLC has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Akari Therapeutics go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and Akari Therapeutics
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 0.67 times more return on investment than Akari Therapeutics. However, DiaMedica Therapeutics is 1.5 times less risky than Akari Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Akari Therapeutics PLC is currently generating about -0.02 per unit of risk. If you would invest 370.00 in DiaMedica Therapeutics on September 12, 2024 and sell it today you would earn a total of 146.00 from holding DiaMedica Therapeutics or generate 39.46% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 99.72% |
| Values | Daily Returns |
DiaMedica Therapeutics vs. Akari Therapeutics PLC
Performance |
| Timeline |
| DiaMedica Therapeutics |
| Akari Therapeutics PLC |
DiaMedica Therapeutics and Akari Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with DiaMedica Therapeutics and Akari Therapeutics
The main advantage of trading using opposite DiaMedica Therapeutics and Akari Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Akari Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akari Therapeutics will offset losses from the drop in Akari Therapeutics' long position.| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
| Akari Therapeutics vs. Equillium | Akari Therapeutics vs. DiaMedica Therapeutics | Akari Therapeutics vs. Valneva SE ADR | Akari Therapeutics vs. Vivani Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |